Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
The FEBS Journal|July 14, 2017
TGF-β1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathwayLanfang Wu, Lingfei Han, Chenfei Zhou, et al.Journal of Translational Medicine|August 12, 2022
Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNAWenqi Xi, Chenfei Zhou, Fei Xu, et al.Oncogene|November 10, 2023
VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent mannerQingqing Zhou, Feng Qi, Chenfei Zhou, et al.Cancers|August 12, 2023
Plasma Exosome Proteins ILK1 and CD14 Correlated with Organ-Specific Metastasis in Advanced Gastric Cancer PatientsChenfei Zhou, Changting Qiao, Jun Ji, et al.Annals of Translational Medicine|June 24, 2021
Development and validation of risk and prognostic nomograms for bone metastases in Chinese advanced colorectal cancer patientsNan Wang, Fangqi Liu, Wenqi Xi, et al.Frontiers in Immunology|June 16, 2020
CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8+ T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor EradicationYanmei Zhang, Nisha Wang, Meilin Ding, et al.Journal of Translational Medicine|January 9, 2025
A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumorsChenfei Zhou, Bin Wang, Christina Teng, et al.Cell Death and Differentiation|September 15, 2020
Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironmentChenfei Zhou, Yanmei Zhang, Ruiming Yan, et al.International Journal of Biological Sciences|May 20, 2026
GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosisYing Sun, Xirui Duan, Benyan Zhang, et al.Future Oncology (London, England)|December 3, 2025
A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19Liting Guo, Chenfei Zhou, Wenqi Xi, et al.Pageof 6